Want to see CCCC full AI Analyst Report?
C4 Therapeutics (CCCC) Q3 2024 Earnings Report
CCCC Q3 2024 EPS Results
- Actual EPS
- -$0.35
- Consensus EPS
- -$0.38
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.55
CCCC Q3 2024 Revenue Results
- Actual Revenue
- $15.36M
- Expected Revenue
- $5.90M
- Beat/Miss
- Beat by +$9.46M
- YoY Revenue Growth
- +38.75%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/31/2024
- Time
- Before Open
- Conference Call
- Thursday, October 31, 2024
CCCC Upcoming Earnings
C4 Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CCCC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | -0.18 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.19- | -0.44 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.23-0.18 | -0.37 | 51.35% (+0.19) | |
| May 12, 2026 | 2026 (Q1) | -0.25-0.20 | -0.37 | 45.95% (+0.17) | |
| Feb 26, 2026 | 2025 (Q4) | -0.29-0.18 | -0.49 | 63.27% (+0.31) | |
| Nov 06, 2025 | 2025 (Q3) | -0.41-0.44 | -0.35 | -25.71% (-0.09) | |
| Aug 07, 2025 | 2025 (Q2) | -0.38-0.37 | -0.26 | -42.31% (-0.11) | |
| May 07, 2025 | 2025 (Q1) | -0.44-0.37 | -0.41 | 9.76% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | -0.49-0.49 | -0.68 | 27.94% (+0.19) | |
| Oct 31, 2024 | 2024 (Q3) | -0.38-0.35 | -0.55 | 36.36% (+0.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed